Invagen Pharms Drug Patent Portfolio
Invagen Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Invagen Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9789064 | Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide | 15 Dec, 2020 | Expired |
Latest Legal Activities on Invagen Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Invagen Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 22 Nov, 2021 | US9789064 |
|
Maintenance Fee Reminder Mailed
Critical
| 07 Jun, 2021 | US9789064 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 17 Oct, 2017 | US9789064 |
|
Recordation of Patent Grant Mailed
Critical
| 17 Oct, 2017 | US9789064 |
|
Email Notification
Critical
| 28 Sep, 2017 | US9789064 |
|
Issue Notification Mailed
Critical
| 27 Sep, 2017 | US9789064 |
| Dispatch to FDC | 13 Sep, 2017 | US9789064 |
|
Application Is Considered Ready for Issue
Critical
| 13 Sep, 2017 | US9789064 |
|
Issue Fee Payment Verified
Critical
| 12 Sep, 2017 | US9789064 |
|
Issue Fee Payment Received
Critical
| 12 Sep, 2017 | US9789064 |
|
Electronic Review
Critical
| 09 Aug, 2017 | US9789064 |
|
Mail Notice of Allowance
Critical
| 09 Aug, 2017 | US9789064 |
|
Email Notification
Critical
| 09 Aug, 2017 | US9789064 |
| Filing Receipt - Updated | 07 Aug, 2017 | US9789064 |
| Letter Accepting Correction of Inventorship Under Rule 1.48 | 07 Aug, 2017 | US9789064 |
Invagen Pharms's Family Patents
Invagen Pharms Drug List
Given below is the complete list of Invagen Pharms's drugs and the patents protecting them.
1. Leuprolide Acetate For Depot Suspension
Leuprolide Acetate For Depot Suspension is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9789064 | Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide |
15 Dec, 2020
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Leuprolide Acetate For Depot Suspension's drug page